NCT07446998Phase 2Active not recruiting

Proof-of-Concept Study Evaluating Total Body Weight, Physical Function & Safety of Enobosarm in Patients Treated With GLP-1 Receptor Agonist, for Weight Loss

Study sponsor: Veru Inc. · VERU

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2027-10Estimated
Enrollment · participants239Actual
Source updated2026-09-04Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 3 fields changed

Participant count type changed

Before: Estimated. After: Actual.

Enrollment · participant count changed

Before: 200 participants (planned). After: 239 participants (actual).

Recruitment status changed

Before: Recruiting. After: Active not recruiting.

Check registry source

· 1 field changed

Recruitment status changed

Before: Not yet recruiting. After: Recruiting.

Check registry source